Home › Cutaneous T-Cell Lymphoma › Texas › Houston
Cutaneous T-Cell Lymphoma clinical trials in Houston, TX
5 studies for Cutaneous T-Cell Lymphoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RecruitingPhase 1
- Md Anderson Cancer Center, Houston
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
RecruitingPhase 2
- MD Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- MD Anderson Cancer Center (Data Collection Only), Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Cutaneous T-Cell Lymphoma trials in other cities
- New York City, NY9 studies
- Baldwin Park, CA8 studies
- Boston, MA5 studies
- New Haven, CT4 studies
- Ann Arbor, MI3 studies
- Chicago, IL3 studies
- Scottsdale, AZ3 studies
- Durham, NC3 studies
- Tampa, FL3 studies
- Columbus, OH3 studies
- Rochester, MN3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.